No Data
No Data
No Data
No Data
No Data
The A-share innovative drug sector boosted in early trading, and First Pharmaceutical Holdings rose more than 8%
Gelonghui, March 27 | First Pharmaceutical Holdings rose more than 8%, followed by Hokuriku Pharmaceutical, Osecon, Eddy Pharmaceutical, Changshan Pharmaceutical, and Hanyu Pharmaceutical.
Gelonghui FinanceMar 27 09:51
First Pharmaceutical Holdings (688197.SH): 1.487,200 restricted shares banned on March 25
On March 15, Gelonghui Holdings (688197.SH) announced that the total number of shares in circulation in the company's current stock listing was 1.487,200 shares. The stock listing and circulation date is March 25, 2024.
Gelonghui FinanceMar 15 19:03
Express News | First Pharmaceutical Holdings: The company's core self-developed products are all in the R&D stage, and no products have been launched to contribute sales revenue
BreakingsMar 14 18:25
Express News | 93 science and technology innovation board companies announced their 2023 performance reports. Hangya Technology's net profit increased the most
BreakingsFeb 23 10:30
First Pharmaceutical Holdings-U (688197) 2023 Annual Performance Report Review: Product Development Promotes Smoothly, Authorization Revenue Increased Significantly
Matters: The company released the 2023 annual results report. The total revenue for 2023 is estimated to be 5.2292 million yuan, an increase of 186.19% over the previous year; net profit due to mother is estimated to be -184 million yuan in 2023, deducted
華創證券Feb 20 15:06
CEO Wenjun Li, Shouyao Holdings (Beijing) Co., LTD.'s (SHSE:688197) Largest Shareholder Sees Value of Holdings Go Down 20% After Recent Drop
Key Insights Shouyao Holdings (Beijing)'s significant insider ownership suggests inherent interests in company's expansion Wenjun Li owns 52% of the company 11% of Shouyao Holdings (Beijing) is h
Simply Wall StFeb 2 06:53
No Data
No Data